A Phase I, Open-Label, Dose-Escalation Study of CC-11006 In Subjects With Low- or Intermediate-1 Risk Myelodysplastic Syndromes

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
A Phase I, Open-Label, Dose-Escalation Study of CC-11006 In Subjects With Low- or Intermediate-1 Risk Myelodysplastic Syndromes.
Epistemonikos ID: 9aeeeac0b76218a02368362bac16ce0f961685da
First added on: May 04, 2024